Market Closed -
Bombay S.E.
03:30:53 14/06/2024 pm IST
|
5-day change
|
1st Jan Change
|
538.9
INR
|
-2.90%
|
|
+2.54%
|
-4.10%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,360
|
2,953
|
1,257
|
4,052
|
8,128
|
7,038
|
Enterprise Value (EV)
1 |
3,111
|
3,455
|
1,413
|
4,697
|
8,269
|
6,962
|
P/E ratio
|
6.78
x
|
14.5
x
|
3.32
x
|
6.69
x
|
7.91
x
|
4.56
x
|
Yield
|
1.38%
|
1.16%
|
3.41%
|
1.27%
|
0.74%
|
0.98%
|
Capitalization / Revenue
|
0.43
x
|
0.42
x
|
0.18
x
|
0.44
x
|
0.64
x
|
0.43
x
|
EV / Revenue
|
0.56
x
|
0.49
x
|
0.21
x
|
0.52
x
|
0.65
x
|
0.42
x
|
EV / EBITDA
|
7.08
x
|
3.51
x
|
1.41
x
|
3.64
x
|
5.58
x
|
3.9
x
|
EV / FCF
|
-23.9
x
|
-72.9
x
|
2.53
x
|
-13.8
x
|
15.5
x
|
-62.1
x
|
FCF Yield
|
-4.18%
|
-1.37%
|
39.5%
|
-7.23%
|
6.47%
|
-1.61%
|
Price to Book
|
0.74
x
|
0.91
x
|
0.4
x
|
1.04
x
|
1.43
x
|
0.94
x
|
Nbr of stocks (in thousands)
|
16,307
|
17,165
|
17,165
|
17,165
|
17,165
|
17,165
|
Reference price
2 |
144.7
|
172.0
|
73.25
|
236.0
|
473.5
|
410.0
|
Announcement Date
|
05/10/18
|
06/09/19
|
06/11/20
|
07/09/21
|
07/09/22
|
04/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
5,511
|
7,021
|
6,891
|
9,108
|
12,673
|
16,501
|
EBITDA
1 |
439.2
|
984.7
|
1,003
|
1,289
|
1,481
|
1,786
|
EBIT
1 |
252.6
|
535.5
|
519.3
|
801.7
|
1,301
|
1,615
|
Operating Margin
|
4.58%
|
7.63%
|
7.54%
|
8.8%
|
10.27%
|
9.79%
|
Earnings before Tax (EBT)
1 |
370.1
|
422.1
|
454.4
|
808.4
|
1,370
|
1,904
|
Net income
1 |
366.1
|
204.3
|
379.1
|
605.7
|
1,028
|
1,543
|
Net margin
|
6.64%
|
2.91%
|
5.5%
|
6.65%
|
8.11%
|
9.35%
|
EPS
2 |
21.33
|
11.90
|
22.08
|
35.29
|
59.88
|
89.87
|
Free Cash Flow
1 |
-130.1
|
-47.37
|
558.6
|
-339.8
|
535.1
|
-112.2
|
FCF margin
|
-2.36%
|
-0.67%
|
8.11%
|
-3.73%
|
4.22%
|
-0.68%
|
FCF Conversion (EBITDA)
|
-
|
-
|
55.71%
|
-
|
36.13%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
147.35%
|
-
|
52.07%
|
-
|
Dividend per Share
2 |
2.000
|
2.000
|
2.500
|
3.000
|
3.500
|
4.000
|
Announcement Date
|
05/10/18
|
06/09/19
|
06/11/20
|
07/09/21
|
07/09/22
|
04/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
751
|
501
|
156
|
645
|
141
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
75.9
|
Leverage (Debt/EBITDA)
|
1.711
x
|
0.5092
x
|
0.1554
x
|
0.5005
x
|
0.0953
x
|
-
|
Free Cash Flow
1 |
-130
|
-47.4
|
559
|
-340
|
535
|
-112
|
ROE (net income / shareholders' equity)
|
14.2%
|
6.35%
|
11.9%
|
17.3%
|
21.5%
|
23.3%
|
ROA (Net income/ Total Assets)
|
3.91%
|
7.2%
|
7.1%
|
10.4%
|
12.4%
|
12%
|
Assets
1 |
9,365
|
2,838
|
5,342
|
5,826
|
8,259
|
12,873
|
Book Value Per Share
2 |
195.0
|
190.0
|
182.0
|
226.0
|
332.0
|
437.0
|
Cash Flow per Share
2 |
1.830
|
1.030
|
24.30
|
4.070
|
8.300
|
15.60
|
Capex
1 |
280
|
449
|
80.6
|
204
|
144
|
83.2
|
Capex / Sales
|
5.08%
|
6.4%
|
1.17%
|
2.24%
|
1.14%
|
0.5%
|
Announcement Date
|
05/10/18
|
06/09/19
|
06/11/20
|
07/09/21
|
07/09/22
|
04/09/23
|
|
1st Jan change
|
Capi.
|
---|
| -0.52% | 98.24B | | -10.90% | 58.77B | | +63.33% | 45.23B | | +12.56% | 37.42B | | -1.62% | 30.46B | | +7.05% | 19.26B | | +11.98% | 16.67B | | +6.45% | 13.6B | | -6.76% | 12.73B |
Other Commodity Chemicals
|